Novel composition comprising rosiglitazone and another antidiabetic agent

Details for Australian Patent Application No. 2004262933 (hide)

Owner SmithKline Beecham (Cork) Limited

Inventors Coles, Peter John; Mudd, Paul Norman Jnr; MacKenzie, Donald Colin

Agent Davies Collison Cave

Pub. Number AU-B-2004262933

PCT Pub. Number WO2005/013956

Priority 0318824.0 11.08.03 GB

Filing date 9 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013956 Priority application(s): WO2005/013956

9 October 2008 Assignment before Grant

  SB Pharmco Puerto Rico Inc. The application has been assigned to SmithKline Beecham (Cork) Limited

10 December 2009 Application Accepted

  Published as AU-B-2004262933

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262934-Topical composition comprising terbinafine and hydrocortisone

2004262927-Combinations comprising staurosporines